Intermittent Fasting: A Novel Approach to Reduce the Risk of Cardiometabolic Disease or Just Another Diet Fad? | Orgain Healthcare Professional Education Series Archive
Over the last decade, intermittent fasting (IF) has emerged as a promising diet intervention to promote cardiometabolic health. IF interventions such as alternate-day fasting, the 5:2 diet, and time-restricted eating have not only been popularized by mainstream media, but a growing body of evidence from clinical trials now suggest that these approaches may enhance health. In this webinar, we will discuss the concept behind intermittent fasting, describe different IF interventions, and review the evidence emerging from recent clinical trials.
Dr. Kristin Hoddy, PhD, RD
Postdoctoral Researcher in Integrated Physiology and Molecular Metabolism
Dr. Kristin Hoddy, PhD, RD, is a postdoctoral researcher in the Integrated Physiology and Molecular Metabolism Lab at Pennington Biomedical Research Center. She earned her dietetic training and doctoral degree from the University of Illinois at Chicago. She has since conducted research at top-tier research institutions to further understand the connection between chronobiology and diet. Kristin draws on her experience in the health and wellness industry to inspire her research interests related to meal timing and the sleep-obesity paradigm.
Presenter
Dr. Kristin Hoddy, PhD, RD
Postdoctoral Researcher in Integrated Physiology and Molecular Metabolism
Course Overview
| Released: | 4/22/21 |
|---|---|
| Expired: | 4/22/24 |
| Duration: | 1:06:55 |
Sponsor Disclosure: Financial support for this presentation was provided by Orgain. The views expressed herein are those of the presenter and do not necessarily represent Orgain's views. The material herein is accurate as of the date it was presented and is for educational purposes only and is not intended as a substitute for medical advice. Reproduction or distribution of these materials is prohibited. ©2026 Orgain, LLC. All rights reserved.